questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins antiviraux
Vaccins antiviraux : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections virales
Tests diagnostiques
Vaccins antiviraux
Tests sérologiques
Symptômes
Vaccins antiviraux
Efficacité des vaccins
Études cliniques
Symptômes
5
Symptômes
Vaccins antiviraux
Effets secondaires
Vaccins antiviraux
Infections virales
Effets secondaires
Types de vaccins
Réponse immunitaire
Infections virales
Symptômes
Prévention
5
Prévention
Vaccins antiviraux
Vaccins antiviraux
Grossesse
Souches virales
Vaccins antiviraux
Vaccination de masse
Immunité collective
Traitements
5
Vaccins antiviraux
Traitements antiviraux
Antiviraux
Infections virales
Vaccins antiviraux
Symptômes
Vaccination
Traitements antiviraux
Vaccins antiviraux
Prévention
Complications
5
Complications
Réactions allergiques
Complications
Vaccins antiviraux
Gestion des complications
Vaccins antiviraux
Profils de complications
Vaccins antiviraux
Facteurs de risque
5
Facteurs de risque
Infections virales
Antécédents médicaux
Vaccination
Voyages
Infections virales
Personnes âgées
Complications
Mode de vie
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins antiviraux : Questions médicales les plus fréquentes",
"headline": "Vaccins antiviraux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins antiviraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-adénovirus",
"alternateName": "Adenovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D062705",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-adénovirus",
"code": {
"@type": "MedicalCode",
"code": "D062705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.024"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA",
"alternateName": "AIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D016915",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA",
"code": {
"@type": "MedicalCode",
"code": "D016915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la COVID-19",
"alternateName": "COVID-19 Vaccines",
"url": "https://questionsmedicales.fr/mesh/D000086663",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la COVID-19",
"code": {
"@type": "MedicalCode",
"code": "D000086663",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin ChAdOx1 nCoV-19",
"alternateName": "ChAdOx1 nCoV-19",
"url": "https://questionsmedicales.fr/mesh/D000090985",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin ChAdOx1 nCoV-19",
"code": {
"@type": "MedicalCode",
"code": "D000090985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.063"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ad26COVS1",
"alternateName": "Ad26COVS1",
"url": "https://questionsmedicales.fr/mesh/D000090984",
"about": {
"@type": "MedicalCondition",
"name": "Ad26COVS1",
"code": {
"@type": "MedicalCode",
"code": "D000090984",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.125"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le cytomégalovirus",
"alternateName": "Cytomegalovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022482",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le cytomégalovirus",
"code": {
"@type": "MedicalCode",
"code": "D022482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.120"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la dengue",
"alternateName": "Dengue Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053059",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la dengue",
"code": {
"@type": "MedicalCode",
"code": "D053059",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie à virus Ebola",
"alternateName": "Ebola Vaccines",
"url": "https://questionsmedicales.fr/mesh/D046129",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie à virus Ebola",
"code": {
"@type": "MedicalCode",
"code": "D046129",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.205"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les herpèsvirus",
"alternateName": "Herpesvirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022283",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les herpèsvirus",
"code": {
"@type": "MedicalCode",
"code": "D022283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la varicelle",
"alternateName": "Chickenpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D019433",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la varicelle",
"code": {
"@type": "MedicalCode",
"code": "D019433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus herpès simplex",
"alternateName": "Herpes Simplex Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022301",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus herpès simplex",
"code": {
"@type": "MedicalCode",
"code": "D022301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie de Marek",
"alternateName": "Marek Disease Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022501",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie de Marek",
"code": {
"@type": "MedicalCode",
"code": "D022501",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antigrippaux",
"alternateName": "Influenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D007252",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antigrippaux",
"code": {
"@type": "MedicalCode",
"code": "D007252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.302"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre l'encéphalite japonaise",
"alternateName": "Japanese Encephalitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre l'encéphalite japonaise",
"code": {
"@type": "MedicalCode",
"code": "D022321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole",
"alternateName": "Measles Vaccine",
"url": "https://questionsmedicales.fr/mesh/D008458",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole",
"code": {
"@type": "MedicalCode",
"code": "D008458",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.404"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiourlien",
"alternateName": "Mumps Vaccine",
"url": "https://questionsmedicales.fr/mesh/D009108",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiourlien",
"code": {
"@type": "MedicalCode",
"code": "D009108",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.488"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les papillomavirus",
"alternateName": "Papillomavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053918",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les papillomavirus",
"code": {
"@type": "MedicalCode",
"code": "D053918",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"alternateName": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18",
"url": "https://questionsmedicales.fr/mesh/D000068857",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"code": {
"@type": "MedicalCode",
"code": "D000068857",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus para-influenza",
"alternateName": "Parainfluenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022241",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus para-influenza",
"code": {
"@type": "MedicalCode",
"code": "D022241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antipoliomyélitiques",
"alternateName": "Poliovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D023321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antipoliomyélitiques",
"code": {
"@type": "MedicalCode",
"code": "D023321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique inactivé",
"alternateName": "Poliovirus Vaccine, Inactivated",
"url": "https://questionsmedicales.fr/mesh/D011054",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique inactivé",
"code": {
"@type": "MedicalCode",
"code": "D011054",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique oral",
"alternateName": "Poliovirus Vaccine, Oral",
"url": "https://questionsmedicales.fr/mesh/D011055",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique oral",
"code": {
"@type": "MedicalCode",
"code": "D011055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie d'Aujeszky",
"alternateName": "Pseudorabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022421",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie d'Aujeszky",
"code": {
"@type": "MedicalCode",
"code": "D022421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.632"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antirabiques",
"alternateName": "Rabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D011819",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antirabiques",
"code": {
"@type": "MedicalCode",
"code": "D011819",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"alternateName": "Respiratory Syncytial Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022261",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"code": {
"@type": "MedicalCode",
"code": "D022261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.730"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-rotavirus",
"alternateName": "Rotavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022243",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-rotavirus",
"code": {
"@type": "MedicalCode",
"code": "D022243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antirubéoleux",
"alternateName": "Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012411",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antirubéoleux",
"code": {
"@type": "MedicalCode",
"code": "D012411",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"alternateName": "Measles-Mumps-Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022542",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"code": {
"@type": "MedicalCode",
"code": "D022542",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA simien",
"alternateName": "SAIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D018449",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA simien",
"code": {
"@type": "MedicalCode",
"code": "D018449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.790"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antivariolique",
"alternateName": "Smallpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012900",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antivariolique",
"code": {
"@type": "MedicalCode",
"code": "D012900",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.859"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les hépatites virales",
"alternateName": "Viral Hepatitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D014761",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les hépatites virales",
"code": {
"@type": "MedicalCode",
"code": "D014761",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite A",
"alternateName": "Hepatitis A Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022362",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D022362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.395"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite B",
"alternateName": "Hepatitis B Vaccines",
"url": "https://questionsmedicales.fr/mesh/D017325",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D017325",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le virus du Nil occidental",
"alternateName": "West Nile Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053060",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le virus du Nil occidental",
"code": {
"@type": "MedicalCode",
"code": "D053060",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.962"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiamaril",
"alternateName": "Yellow Fever Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022341",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiamaril",
"code": {
"@type": "MedicalCode",
"code": "D022341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.970"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux",
"alternateName": "Viral Vaccines",
"code": {
"@type": "MedicalCode",
"code": "D014765",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yukai Huang",
"url": "https://questionsmedicales.fr/author/Yukai%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Xiao Guo",
"url": "https://questionsmedicales.fr/author/Xiao%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Yuancheng Zhou",
"url": "https://questionsmedicales.fr/author/Yuancheng%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Dongying Liu",
"url": "https://questionsmedicales.fr/author/Dongying%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Jingrui Mao",
"url": "https://questionsmedicales.fr/author/Jingrui%20Mao",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Association between the pan-immune-inflammation value and coronary collateral circulation in chronic total coronary occlusive patients.",
"datePublished": "2024-08-28",
"url": "https://questionsmedicales.fr/article/39198732",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12872-024-04139-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of alpha-adrenergic receptor blockade on coronary circulation in postmenopausal women.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37368136",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00421-023-05267-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sympathetic control of the coronary circulation during trigeminal nerve stimulation in humans.",
"datePublished": "2023-05-14",
"url": "https://questionsmedicales.fr/article/37179503",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00421-023-05208-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37291456",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-023-03294-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between the atherogenic index of plasma and coronary collateral circulation in patients with chronic total occlusion.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39009987",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12872-024-03992-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins antiviraux",
"item": "https://questionsmedicales.fr/mesh/D014765"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins antiviraux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins antiviraux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins antiviraux",
"description": "Comment diagnostiquer une infection virale ?\nQuels tests sont utilisés pour les vaccins antiviraux ?\nLes symptômes indiquent-ils un besoin de vaccin ?\nComment évaluer l'efficacité d'un vaccin ?\nLes tests de dépistage sont-ils nécessaires avant vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Coronary+Circulation#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins antiviraux",
"description": "Quels symptômes nécessitent un vaccin antiviral ?\nLes effets secondaires des vaccins sont-ils fréquents ?\nComment distinguer une infection d'un effet secondaire ?\nLes symptômes varient-ils selon le type de vaccin ?\nLes symptômes d'une infection virale sont-ils similaires ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Coronary+Circulation#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins antiviraux",
"description": "Comment les vaccins antiviraux préviennent-ils les infections ?\nÀ quel âge doit-on commencer la vaccination antivirale ?\nLes vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?\nLes vaccins protègent-ils contre toutes les souches virales ?\nQuelle est l'importance de la vaccination de masse ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Coronary+Circulation#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins antiviraux",
"description": "Les vaccins antiviraux sont-ils des traitements ?\nQuels traitements sont disponibles après infection ?\nLes vaccins peuvent-ils réduire la gravité des symptômes ?\nLes traitements sont-ils nécessaires après vaccination ?\nLes vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Coronary+Circulation#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins antiviraux",
"description": "Quelles complications peuvent survenir après vaccination ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications post-vaccinales ?\nLes complications varient-elles selon le vaccin ?\nLes complications peuvent-elles affecter l'immunité ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Coronary+Circulation#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins antiviraux",
"description": "Quels sont les facteurs de risque pour les infections virales ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes voyages augmentent-ils le risque d'infection ?\nLes personnes âgées ont-elles plus de risques ?\nLe mode de vie influence-t-il le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Coronary+Circulation#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les vaccins antiviraux ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité."
}
},
{
"@type": "Question",
"name": "Les symptômes indiquent-ils un besoin de vaccin ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un vaccin ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils nécessaires avant vaccination ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un vaccin antiviral ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Les effets secondaires des vaccins sont-ils fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers."
}
},
{
"@type": "Question",
"name": "Comment distinguer une infection d'un effet secondaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de vaccin ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection virale sont-ils similaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue."
}
},
{
"@type": "Question",
"name": "Comment les vaccins antiviraux préviennent-ils les infections ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques."
}
},
{
"@type": "Question",
"name": "À quel âge doit-on commencer la vaccination antivirale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Les vaccins protègent-ils contre toutes les souches virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la vaccination de masse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles après infection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils réduire la gravité des symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils nécessaires après vaccination ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après vaccination ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications post-vaccinales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le vaccin ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter l'immunité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les infections virales ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la vaccination ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques."
}
},
{
"@type": "Question",
"name": "Les personnes âgées ont-elles plus de risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutics, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Provincial Department of Education, Key Laboratory of Infectious Disease & Bio-Safety, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, Malaysia.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. dailp@im.ac.cn.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
McMaster Immunology Research Centre and Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada. Electronic address: xingz@mcmaster.ca.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
, Rockville, MD, USA. halsteads@erols.com.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: Naina.mccann@paediatrics.ox.ac.uk.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy; GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: cristina.decastro@unina.it.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Publications dans "Vaccins antiviraux" :
Inflammation and immunity play important roles in the formation of coronary collateral circulation (CCC). The pan-immune-inflammation value (PIV) is a novel marker for evaluating systemic inflammation...
This retrospective study enrolled 1150 patients who were diagnosed with CTO through coronary angiographic (CAG) examinations from January 2013 to December 2021 in China. The Cohen-Rentrop criteria wer...
A significant relationship between the PIV and the formation of CCC was observed in our study. Utilizing multivariate logistic regression and adjusting for confounding factors, the PIV emerged as an i...
PIV was associated with the formation of CCC. Notably, PIV exhibited potential as a predictor for poor CCC formation and showcased superior predictive performance compared to other complete blood coun...
We sought to investigate the effect of the α1-adrenergic receptor blockade during handgrip exercise (Grip), isolated metaboreflex activation (Metabo), and cold pressor test (CPT) on coronary circulati...
We sought to investigate the sympathetic mechanism controlling coronary circulation during trigeminal nerve stimulation in healthy women....
The protocol consisted of 3 min of trigeminal nerve stimulation (TGS) with cold stimuli to the face, in two conditions: (1) control and β-blockade (oral propranolol), and (2) control and α-blockade (o...
Thirty-one healthy young subjects (women: n = 13; men: n = 18) participated in the study. By design, TGS decreased heart rate (HR), and increased blood pressure (BP) and cardiac output (CO). Before th...
Coronary circulation increases during sympathetic stimulation even with a decrease in heart rate....
The role of coronary collateral circulation has been thoroughly studied, and myocardial perfusion imaging has been a frequently employed method. Even angiographic invisible collaterals can support som...
The atherogenic index of plasma (AIP) is considered an independent risk factor for coronary artery disease (CAD). The present study investigated whether AIP correlates with the formation of coronary c...
This retrospective study included 1093 CAD patients with CTO confirmed by coronary angiography from January 2020 to December 2020 at Beijing Anzhen Hospital. Based on the Rentrop scoring system, the p...
Patients in the poor CCC group exhibited significantly higher AIP compared to those in the good CCC group (0.31 ± 0.27 vs. 0.14 ± 0.24, p < 0.001). Multivariate logistic regression analysis revealed a...
Elevated AIP is independently associated with an increased risk of poor CCC in CAD patients with CTO, and AIP may improve the ability to identify poor CCC in clinical practice....
Early and long-term outcomes in patients with pulmonary atresia-intact ventricular septum undergoing staged univentricular palliations have been known to be adversely affected by the presence of right...
Up to one third of patients with pulmonary atresia with intact ventricular septum (PA-IVS) will have inadequate anterograde coronary blood flow and rely on fistulous connections from the right ventric...
Coronary function testing in patients with ischemia and nonobstructive coronary arteries (INOCA) commonly includes assessment of adenosine-mediated vasodilation and acetylcholine spasm provocation. Th...
In this retrospective cohort study, we included patients with INOCA who underwent clinically indicated comprehensive coronary function testing. Endothelial dysfunction was defined as a <50% increase i...
Among all 110 patients, 79% had endothelial dysfunction, 62% had CAS, and 29% had an impaired adenosine-mediated vasodilation. Endothelial dysfunction was present in 80% of patients who tested positiv...
Concomitant endothelial dysfunction was prevalent in the vast majority of patients with INOCA with inducible CAS and/or an impaired adenosine-mediated vasodilation. In patients with INOCA without indu...
Coronary artery disease (CAD) is frequent, but coronary slow flow (CSF) is a less common cardiovascular disease with a significant risk of mortality and morbidity. Endocan is a proinflammatory glycope...
In the trial, we included 169 consecutive subjects having a coronary angiography indication. According to the results of coronary angiography, 58 people were included in the CAD group, 52 were in the ...
Notably, 2.6% of the population in our study had CSF. Both the CAD (555±223 pg/mL) and CSF (559±234 pg/mL) groups had higher endocan levels than the control group (331±252 pg/mL) (p<0.001). There were...
Endocan levels are higher in CAD and CSF patients than in those with normal coronary arteries....
Coronary microvascular dysfunction (CMD) is a key mechanism underlying ischemic heart disease (IHD), yet its diagnosis and treatment remain challenging. This article presents a comprehensive overview ...